CPD On Demand


csem accredited program

CSEM Member–Only Access on Demand


Hypocalcemia Revisited - A CSEM Knowledge Transfer Activity (KTA)

register

Tuesday, June 28, 2022, from 7:30 to 9:30 PM ET


Dr. Aliya Khan, a trailblazer in bone and mineral research, will lead a case-based approach to the urgent, emergent, and chronic management of hypocalcemia. Are you wondering what to do beyond standard treatments, including what to do in pregnancy? We’ll explore the role of active vitamin D, parathyroid hormone and PTH analogues, and calcium-sparing diuretics. Discussion will also include the role of genetics in the development of nonsurgical hypoparathyroidism and how obtaining a molecular diagnosis can guide your management approach.

This self-assessment program will include pre- and post- tests using live polling during the session to allow you to claim Section 3 credits.

FACULTY:

  • Dr. Christopher Tran, The Ottawa Hospital, Ottawa (KTA Chair, Moderator)
  • Dr. Aliya Khan, McMaster, Hamilton (Presenter)
  • Dr. Elizabeth Rosolowsky, University of Alberta, Edmonton (CSEM CPD Chair)

SESSION OBJECTIVES: At the end of this session participants will be able to:

  • Identify key considerations in the management of hypocalcemia beyond standard treatments
  • Develop a rational approach to diagnosing the underlying cause of hypocalcemia, including when a genetic cause should be considered
  • Understand the changes in calcium homeostasis in pregnancy and how this will impact your management of hypoparathyroidism during pregnancy

Sponsored by BridgeBio Pharma, Inc.

CSEM's 2021–2022 Knowledge Transfer Activities were planned independently by CSEM to ensure scientific integrity, objectivity and balance.



1st Annual Canadian Cushing’s Summit

Updates on the diagnosis and management of Cushing's syndrome, featuring a panel of national and international experts.

register

Tuesday, May 31, 2022, from 6:30 PM to 9:30 PM ET


Join us for the first annual Canadian online summit focusing on updates to the diagnosis and management of Cushing’s syndrome.

GUEST SPEAKERS:

  • Dr. Lynnette Nieman, National Institute of Health, Bethesda, Maryland, USA
  • Dr. Frédéric Castinetti, Aix Marseille Université, Marseille Medical Genetics, Marseille, FR

FACULTY:

  • Dr. André Lacroix, CHUM, Montréal (Chair, Presenter)
  • Dr. Fabienne Langlois, Université de Sherbrooke, Sherbrooke (Presenter)
  • Dr. Karen Gomez Hernandez, University Health Network (Presenter)
  • Dr. Robert Goldberg, CSEM CPD Rep, University of Toronto (CPD Representative)

SESSION OBJECTIVES: At the end of this session participants will be able to:

  • Describe updates on the diagnosis and management of Cushing’s disease from the Pituitary Society’s October 2021 guideline update
  • Summarize the use of the desmopressin test in the investigation and follow up of Cushing’s disease
  • Outline an approach to the management of mild dysregulated cortisol secretion

This program is co-developed with Recordati Rare Diseases and planned independently by CSEM to achieve scientific integrity, validity, and balance.



Diabetes & Endocrinology Research Year-in-Review

December 8, 2021


watch now

Moderated by Dr. Hertzel Gerstein, this two-hour, accredited online symposium features a review of the key scientific developments in endocrinology and diabetes over the past year. Dr. Amel Arnaout and Dr. Jeremy Gilbert will synthesize and discuss within the Canadian context research from major conferences such as ENDO Society, EASD and ADA.

At the end of this symposium, participants will be able to:

  • synthesize key scientific developments in diabetes and endocrinology over the past year
  • evaluate the relevance and implications for diabetes management within a Canadian context
  • identify important elements of emerging research that can be applied to clinical practice

This learning activity was planned independently by CSEM to achieve scientific integrity, objectivity, and balance. CSEM received educational grants from: Lilly, Novo Nordisk and Sanofi.


3rd Canadian Acromegaly Summit

October 29, 2021


watch now

acrosumm21


Simplifying Insulin Regimens: When, Why, and How to Initiate and Intensify Insulin in Type 2 Diabetes

Wednesday, October 20, 2021

diabmanage

watch now

Join us for the third webinar in the Diabetes Management series. With insulin initiation being a major area for clinical inertia, this webinar will focus on challenges and barriers to insulin initiation and provide guidance on when insulin should be considered and the regimens to use for patients. This will review key considerations for these patients from a holistic approach to diabetes management.

FACULTY:

  • Dr. David Strain, MBChB, MD, FRCP (Moderator)
  • Dr. Roopa Mehta, MBBS, MRCP
  • Dipesh Patel, BSc, MBBS PhD, MRCP
  • Rene Wong, MD, FRCPC, MEd

LEARNING OBJECTIVES:

  • Review the role of insulin in the management of type 2 diabetes
  • Determine which patients are candidate for the use of basal insulin
  • Mitigate patient and clinician barriers to using insulin in type 2 diabetes
  • Prescribe and intensify an insulin regimen for patients with type 2 diabetes

This program has been supported by an independent educational grant provided by Novo Nordisk A/S.

The Diabetes Management series has been developed in collaboration with the following partners:
diabmanagecollab


Maladie de Cushing : choix, défis et complications
Diagnostic, thérapies et complications difficiles dans la gestion de la maladie de Cushing

Le 7 octobre 2021


watch now

Ce séminaire en ligne sur la maladie de Cushing a porté sur les nouveaux développements en matière de diagnostic, de traitement et de stratégies de gestion.

FACULTÉ :

  • Dr André Lacroix, CHUM, Montréal (Président, Comité de planification scientifique et conférencier)
  • Dre Jessica MacKenzie-Feder, University of British Columbia, Vancouver (conférencière)
  • Dre Fabienne Langlois, Université de Sherbrooke, Sherbrooke (conférencière)
  • Dre Karen Gomez Hernandez, University Health Network (modératrice)
  • Dr Robert Goldberg, CSEM CPD Rep, University of Toronto (Représentant de la DPC)

OBJECTIFS : À la fin de la séance, les participants pourront :

  • intégrer des stratégies pour améliorer les défis dans l’investigation et diagnostique de la maladie de Cushing
  • comparer et contraster les choix de thérapies et les thérapies médicales
  • évaluer les complications et comorbidités possibles au fil du temps

CSEM Research and Discovery Day: From Bench to Bedside: Lessons Still to be Learned a Century After the Discovery of Insulin

October 1, 2021


watch now

A century ago, Canadian researchers Frederick Banting and Charles Best, discovered insulin working under the directorship of John Macleod at the University of Toronto; further work by James Collip led to the additional purification of insulin. With incredible speed and collaboration, insulin was ready to use to save the lives of people with Type 1 diabetes mellitus. This scientific breakthrough was one of the most important advancements in medical history.

Using this ground-breaking discovery as a framework, the symposium connected, engaged, informed and supported endocrinologists in their work as researchers and clinicians. Key developments and anecdotes from past research framed current parallels in emerging research and the current management of diabetes and comorbidities to illustrate lessons learned and the potential of future discoveries.

FACULTY:

  • Dr. Gillian Booth, Li Ka Shing Knowledge Institute of St. Michael's Hospital
  • Dr. Greg Korbutt, Alberta Diabetes Institute, University of Alberta
  • Dr. Mark Prentki, University of Montreal, Montreal Diabetes Research Center
  • Dr. Ronald Sigal, Cumming School of Medicine and Faculty of Kinesiology, University of Calgary
  • Dr. Donna Vine, Alberta Diabetes Institute, University of Alberta

For the AGENDA, click here.

CSEM's Research and Discovery Day has received educational grants from Novo Nordisk Canada, Lilly, and MD Financial. The Research Day is planned independently by CSEM to ensure scientific integrity, objectivity and balance.


Cushing’s Disease: Choices, Challenges and Complications
Diagnosis, Therapies and Challenging Complications in the Management of Cushing’s Disease

September 28, 2021


watch now

This online seminar on Cushing’s disease focused on new developments in diagnosis, treatment and management strategies.

FACULTY:

  • Dr André Lacroix, CHUM, Montréal (Chair, Presenter)
  • Dre Jessica MacKenzie-Feder, University of British Columbia, Vancouver (Presenter)
  • Dre Fabienne Langlois, Université de Sherbrooke, Sherbrooke (Presenter)
  • Dre Karen Gomez Hernandez, University Health Network (Moderator)
  • Dr Robert Goldberg, CSEM CPD Rep, University of Toronto (CPD Representative)

OBJECTIVES : At the end of this session participants will be able to:

  • apply strategies to mitigate challenges in the investigation and diagnosis of Cushing’s disease
  • compare and contrast treatment choices and medical therapies
  • assess possible complications and comorbidities over time

CSEM Knowledge Transfer Activities


watch now

May 12, 2021: KTA #3 — Challenging Diabetes: Hyperglycemia in Cushing’s and Acromegaly

At the end of this session, you will be able to:

  • Describe the unique challenges of managing diabetes in Cushing’s Syndrome and acromegaly
  • Describe how treatment of Cushing’s Disease and acromegaly can affect glycemia
  • Apply motivational interviewing techniques to support improved health and well-being
  • Recognize the importance of multi-disciplinary approach

KTA #2 — Androgen Misuse and Abuse

>April 28, 2021

An interactive and in-depth discussion that featured international experts to help navigate the challenging and controversial topic.

At the end of this session, you will be able to:

  • Discuss laboratory features suggestive of androgen misuse/abuse
  • Discuss impact of androgen misuse/abuse including hypogonadism in men
  • Identify counseling strategies for patients
  • Recognize key considerations for endocrinologists when consulted by family physicians

April 14, 2021: KTA #1 — Growth Hormone Deficiency: New Options for Treatment & Long-Acting Therapies

An engaging, interactive presentation and discussion on advances in growth hormone therapy.

At the end of this session, you will be able to:

  • Describe pediatric and adult indications for prescribing growth hormone (GH)
  • Discuss barriers that limit adherence to GH replacement treatments and strategies to mitigate them
  • Compare efficacy of daily treatment vs long-acting treatment


2nd Annual Canadian Acromegaly Summit: The Journey of Acromegaly Patients During the Pandemic

November 13, 2020


watch now

Part 1: Acromegaly Summit Lectures - Management of Acromegaly; Acromegaly and Psychiatric Inequality; Quality of Life in Acromegaly; Management of Patients with Acromegaly during the COVID-19 Pandemic

Part 2: Acromegaly Case Discussions:

  • Case 1 — illustrated some indications for screening, broad differential diagnoses, ranging from lab issues, delayed puberty, exogenous use, early or latent acromegaly to clinically silent somatotroph adenomas
  • Case 2 — illustrated medical treatment strategies (options) with an emphasis on pre-operative medical management of patients with acromegaly

At the end of this session, participants will be able to:

  • Define the best practice in the investigation and management of comorbidities in patients with acromegaly
  • Recognize the psychopathology in patients with acromegaly and the gender bias
  • Identify factors that contribute to the impaired quality of life in patients with acromegaly
  • Appreciate the potential impact of the COVID-19 infection and the challenges associated with the care of acromegaly patients during the pandemic

Your Changing Practice: The Impact of COVID-19 on Endocrinologists — COVID-19, Adrenal Insufficiency, and Stress Management: For Your Patients (and You)

June 25, 2020


watch now

This discussion forum focused on stress management for physicians and their patients during the pandemic situation, specifically patients with adrenal insufficiency and diabetes.

At the end of this session, participants will be able to:

  • Address in an empathetic way the concerns of patients living with Addison’s Disease, Hypopituitarism and Diabetes during a pandemic (fears regarding health as well as access to medications and medical resources)
  • Describe sick-day dosing rules and emergency protocols
  • Discuss impact of stress on patient health
  • Apply strategies to maintain balance in their own lives: stress management techniques

Your Changing Practice: The Impact of COVID-19 on Endocrinologists — Virtual Care Discussion Forum

June 11, 2020


watch now

This discussion forum focused on stress management for physicians and their patients during the pandemic situation, specifically patients with adrenal insufficiency and diabetes.

At the end of this session, participants will be able to:

  • Describe appropriately informed and optimal virtual practice
  • Discuss limitations of virtual practice and recognize clues to minimize lapses in care
  • Consider impacts of transitioning to and back from virtual practice — what next?
  • Utilize effective communication: planning and implementation



Some Endocrine Society’s ESAP programs have been reviewed and approved by CSEM for Section 3 credits. You may claim a maximum of 40 hours. Credits are calculated automatically in MAINPORT.

Accredited by CSEM:


Not yet accredited:




mdbriefcase

Current courses in the field of Endocrinology offered by mdBriefCase are available on their website. These programs are designed to further the knowledge of healthcare professionals with the ultimate goal of improving patient care.

Note: you must be logged into mdBriefCase's website to access these courses. Registration is free to CSEM members.